Volume
Open
Day's Low
Day's High
52 Wk Low
52 Wk High
Bid
Ask
EPS
PE Ratio
Shares
Market Cap
Dividend
Ex-Div Date
Yield
Do You Like Swing Trading?
Learn how we win with easy 3-5 day holds.
Be 'active' in the market while NOT being tied to your desk.
Be 'active' in the market while NOT being tied to your desk.
...
Health Technology » Biotechnology
| symbol | company | %chng | last | %short | avg$volume | |
|---|---|---|---|---|---|---|
| MRNA | Moderna, Inc. | 8.73% | 147.66 | 0.0% | $994.17m | |
| AMGN | Amgen, Inc. | 0.87% | 255.26 | 1.5% | $856.48m | |
| GILD | Gilead Sciences, Inc. | 0.51% | 64.80 | 1.0% | $543.24m | |
| VRTX | Vertex Pharmaceuticals, Inc. | 1.51% | 273.73 | 1.9% | $497.98m | |
| REGN | Regeneron Pharmaceuticals, Inc. | 1.37% | 692.80 | 2.6% | $444.80m | |
| ILMN | Illumina, Inc. | 5.95% | 258.06 | 3.3% | $337.13m | |
| NVAX | Novavax, Inc. | 17.46% | 55.29 | 75.7% | $314.14m | |
| BIIB | Biogen, Inc. | 0.97% | 206.20 | 1.8% | $237.64m | |
| BNTX | BioNTech SE | 5.57% | 166.96 | 0.0% | $224.59m | |
| SNSS | Sunesis Pharmaceuticals, Inc. | 2.38% | 2.15 | 0.7% | $150.29m | |
| EXAS | EXACT Sciences Corp. | 7.96% | 53.83 | 17.7% | $134.25m | |
| TECH | Bio-Techne Corp. | 5.81% | 386.56 | 4.5% | $107.96m | |
| TXG | 10X Genomics, Inc. | 11.91% | 52.99 | 0.0% | $106.79m | |
| BMRN | BioMarin Pharmaceutical, Inc. | 2.68% | 80.97 | 4.2% | $95.42m | |
| CRSP | CRISPR Therapeutics AG | 5.63% | 58.34 | 0.6% | $85.42m |
Company Profile
Cortexyme, Inc. is a biopharmaceutical company, which engages in the development and commercialization of therapeutics. Its pipeline composed of COR388, COR588, COR788, COR822, and Coronavirus 3CL protease inhibitor. The company was founded by Casey Crawford Lynch, Stephen Dominy, and Kristen Gafric on June 20, 2012 and is headquartered in South San Francisco, CA.